| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.77▼ | 1.75▲ | 1.75▼ | 1.76▲ | 1.97▼ |
| MA10 | 1.76▼ | 1.76▼ | 1.77▼ | 1.84▼ | 2.29▼ |
| MA20 | 1.82▼ | 1.85▼ | 1.86▼ | 1.96▼ | 2.68▼ |
| MA50 | 1.93▼ | 1.96▼ | 1.98▼ | 2.37▼ | 3.89▼ |
| MA100 | 2.05▼ | 2.11▼ | 2.19▼ | 2.74▼ | 2.44▼ |
| MA200 | 2.34▼ | 2.50▼ | 2.59▼ | 3.52▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.002▼ | -0.003▼ | 0.002▲ | -0.084▼ |
| RSI | 38.884▼ | 38.906▼ | 38.669▼ | 26.752▼ | 30.522▼ |
| STOCH | 47.534 | 28.360 | 23.545 | 8.219▼ | 5.867▼ |
| WILL %R | -72.222 | -83.333▼ | -83.333▼ | -80.000▼ | -94.156▼ |
| CCI | -48.166 | -53.392 | -58.539 | -86.942 | -122.100▼ |
|
Tuesday, June 23, 2026 05:23 AM
On track for enrollment of 80 participants by Q1 2027 Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer ...
|
|
Monday, June 22, 2026 01:31 PM
IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that Stacy Lindborg, Ph.D., President and Chief Executive Officer of ...
|
|
Friday, June 05, 2026 05:30 AM
On May 4, 2026, Imunon, Inc. (NASDAQ: IMNN) announced a uniquely structured financing expected to provide up to $10 million in gross proceeds, helping to bolster the company's balance sheet as it ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/06/26 | 1.73 | 1.845 | 1.71 | 1.79 | 72,465 |
| 25/06/26 | 1.83 | 1.83 | 1.70 | 1.72 | 48,230 |
| 24/06/26 | 1.84 | 1.856 | 1.73 | 1.73 | 61,631 |
| 23/06/26 | 1.81 | 1.9154 | 1.7501 | 1.78 | 82,215 |
| 22/06/26 | 1.86 | 1.86 | 1.7749 | 1.80 | 18,417 |
| 18/06/26 | 1.88 | 1.8917 | 1.80 | 1.82 | 30,650 |
| 17/06/26 | 2.04 | 2.05 | 1.811 | 1.86 | 447,693 |
| 16/06/26 | 1.95 | 1.975 | 1.86 | 1.88 | 56,982 |
| 15/06/26 | 1.99 | 2.0602 | 1.95 | 1.95 | 29,000 |
| 12/06/26 | 2.01 | 2.15 | 1.94 | 2.02 | 45,917 |
|
|
||||
|
|
||||
|
|